Cryo-Cell International, Inc. revenue for the last year amounted to 31.30 M USD, the most of which — 30.80 M USD — came from its highest performing source at the moment, Umbilical Cord Blood and Cord Tissue Stem Cell Service, the year earlier bringing 29.77 M USD. The greatest contribution to the revenue figure was made by United States — last year it brought Cryo-Cell International, Inc. 31.34 M USD, and the year before that — 30.34 M USD.